Literature DB >> 21940159

Volumetric modulated arc radiotherapy for esophageal cancer.

Nagarajan Vivekanandan1, Padmanaban Sriram, S A Syam Kumar, Narayanan Bhuvaneswari, Kamalakannan Saranya.   

Abstract

A treatment planning study was performed to evaluate the performance of volumetric arc modulation with RapidArc (RA) against 3D conformal radiation therapy (3D-CRT) and conventional intensity-modulated radiation therapy (IMRT) techniques for esophageal cancer. Computed tomgraphy scans of 10 patients were included in the study. 3D-CRT, 4-field IMRT, and single-arc and double-arc RA plans were generated with the aim to spare organs at risk (OAR) and healthy tissue while enforcing highly conformal target coverage. The planning objective was to deliver 54 Gy to the planning target volume (PTV) in 30 fractions. Plans were evaluated based on target conformity and dose-volume histograms of organs at risk (lung, spinal cord, and heart). The monitor unit (MU) and treatment delivery time were also evaluated to measure the treatment efficiency. The IMRT plan improves target conformity and spares OAR when compared with 3D-CRT. Target conformity improved with RA plans compared with IMRT. The mean lung dose was similar in all techniques. However, RA plans showed a reduction in the volume of the lung irradiated at V(₂₀Gy) and V(₃₀Gy) dose levels (range, 4.62-17.98%) compared with IMRT plans. The mean dose and D(₃₅%) of heart for the RA plans were better than the IMRT by 0.5-5.8%. Mean V(₁₀Gy) and integral dose to healthy tissue were almost similar in all techniques. But RA plans resulted in a reduced low-level dose bath (15-20 Gy) in the range of 14-16% compared with IMRT plans. The average MU needed to deliver the prescribed dose by RA technique was reduced by 20-25% compared with IMRT technique. The preliminary study on RA for esophageal cancers showed improvements in sparing OAR and healthy tissue with reduced beam-on time, whereas only double-arc RA offered improved target coverage compared with IMRT and 3D-CRT plans. Copyright Â
© 2012 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21940159     DOI: 10.1016/j.meddos.2011.01.008

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  10 in total

Review 1.  Advances in radiotherapy for esophageal cancer.

Authors:  Wei Deng; Steven H Lin
Journal:  Ann Transl Med       Date:  2018-02

Review 2.  Esophageal cancer management controversies: Radiation oncology point of view.

Authors:  Patricia Tai; Edward Yu
Journal:  World J Gastrointest Oncol       Date:  2014-08-15

3.  Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.

Authors:  Guanzhong Gong; Ruozheng Wang; Yujie Guo; Deyin Zhai; Tonghai Liu; Jie Lu; Jinhu Chen; Chengxin Liu; Yong Yin
Journal:  Radiat Oncol       Date:  2013-12-20       Impact factor: 3.481

4.  What Is the Optimal Radiation Technique for Esophageal Cancer? A Dosimetric Comparison of Four Techniques.

Authors:  Ziad Simon Fawaz; Suzanne Kazandjian; James M Tsui; Dr Slobodan Devic; Magali Lecavalier-Barsoum; Te Vuong; Sara Elakshar; Aurelie Garant; Isabelle Lavoie; Tamin M Niazi
Journal:  Cureus       Date:  2018-07-16

5.  Radiation Pneumonitis after Intensity-Modulated Radiotherapy for Esophageal Cancer: Institutional Data and a Systematic Review.

Authors:  J J Tonison; S G Fischer; M Viehrig; S Welz; S Boeke; K Zwirner; B Klumpp; L H Braun; D Zips; C Gani
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

Review 6.  Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.

Authors:  Daniel Buergy; Frank Lohr; Tobias Baack; Kerstin Siebenlist; Stefan Haneder; Henrik Michaely; Frederik Wenz; Judit Boda-Heggemann
Journal:  Radiat Oncol       Date:  2012-11-16       Impact factor: 3.481

7.  A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers.

Authors:  Antonella Fogliata; Giorgia Nicolini; Alessandro Clivio; Eugenio Vanetti; Sarbani Laksar; Angelo Tozzi; Marta Scorsetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2015-10-31       Impact factor: 3.481

8.  CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer.

Authors:  Xiance Jin; Jinling Yi; Yongqiang Zhou; Huawei Yan; Ce Han; Congying Xie
Journal:  J Appl Clin Med Phys       Date:  2013-09-06       Impact factor: 2.102

9.  Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?

Authors:  Zhiqin Wu; Congying Xie; Meilong Hu; Ce Han; Jinling Yi; Yongqiang Zhou; Huawei Yuan; Xiance Jin
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

Review 10.  Radiation Matters of the Heart: A Mini Review.

Authors:  Kareena M Menezes; Huichen Wang; Megumi Hada; Premkumar B Saganti
Journal:  Front Cardiovasc Med       Date:  2018-07-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.